NUTM2A and endometrioid stromal sarcoma: A major diagnostic breakthrough occurred in 2012, with identification of the t (10;17) (q22;p13) YWHAE-FAM22A/B (NUTM2A/B) fusion, now considered the molecular hallmark of high-grade endometrial stromal sarcoma (HG-ESS).